News | October 11, 2024
OneSource unveils new brand identity at CPHI Milan
Aims to achieve CDMO sales of US$ 400 million by 2028
Aims to achieve CDMO sales of US$ 400 million by 2028
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
This agreement paves the way for the introduction of YESAFILI into the Canadian market
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Receives registration of Valganciclovir powder for oral solution in Germany
The new ECO grade is made using renewable feedstock
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Subscribe To Our Newsletter & Stay Updated
